Literature DB >> 16824650

Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT.

Chaorui Huang1, David Eidelberg, Christian Habeck, James Moeller, Leif Svensson, Tyler Tarabula, Per Julin.   

Abstract

This study aimed to investigate cross-sectional and longitudinal changes of regional cerebral blood flow (rCBF) in preclinical dementia using single photon emission computed tomography (SPECT). SPECT and cognitive function were investigated in 39 mild cognitive impairment (MCI) subjects and 20 age-matched controls. All subjects were followed longitudinally 19 months on average, 16 MCI subjects progressed to Alzheimer's disease (AD), who were retrospectively defined as progressive mild cognitive impairment (PMCI) at baseline and 23 MCI subjects remained stable and were defined as stable mild cognitive impairment (SMCI) at baseline. SPECT was performed both at the initial investigation and at follow-up. Image data were analyzed using multivariate analysis, SPM and volume of interest (VOI)-based analysis. Significant covariate patterns were derived, which differentiate among PMCI, SMCI and controls at baseline as well as describe the longitudinal progression of PMCI. The combined SPECT and neuropsychology increased the diagnostic accuracy of PMCI at baseline. SPECT and neuropsychological testing can be used objectively for both baseline diagnosis and to monitor changes in brain function during very early AD.

Entities:  

Mesh:

Year:  2006        PMID: 16824650     DOI: 10.1016/j.neurobiolaging.2006.05.017

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  20 in total

1.  Metabolic brain networks associated with cognitive function in Parkinson's disease.

Authors:  Chaorui Huang; Paul Mattis; Chengke Tang; Kenneth Perrine; Maren Carbon; David Eidelberg
Journal:  Neuroimage       Date:  2006-11-17       Impact factor: 6.556

2.  Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease.

Authors:  Christian Habeck; Norman L Foster; Robert Perneczky; Alexander Kurz; Panagiotis Alexopoulos; Robert A Koeppe; Alexander Drzezga; Yaakov Stern
Journal:  Neuroimage       Date:  2008-02-14       Impact factor: 6.556

Review 3.  Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  J Neural Transm (Vienna)       Date:  2015-05-06       Impact factor: 3.575

4.  A review of neuroimaging biomarkers of Alzheimer's disease.

Authors:  Tinu Varghese; R Sheelakumari; Jija S James; Ps Mathuranath
Journal:  Neurol Asia       Date:  2013       Impact factor: 0.183

5.  Carvacrol suppresses learning and memory dysfunction and hippocampal damages caused by chronic cerebral hypoperfusion.

Authors:  Azadeh Shahrokhi Raeini; Zeynab Hafizibarjin; Mohammad Ebrahim Rezvani; Fatemeh Safari; Faezeh Afkhami Aghda; Fatemeh Zare Mehrjerdi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-11-15       Impact factor: 3.000

Review 6.  Functional imaging of cerebral blood flow and glucose metabolism in Parkinson's disease and Huntington's disease.

Authors:  Yilong Ma; David Eidelberg
Journal:  Mol Imaging Biol       Date:  2007 Jul-Aug       Impact factor: 3.488

7.  Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.

Authors:  Flavio Nobili; Giovanni B Frisoni; Florence Portet; Frans Verhey; Guido Rodriguez; Anna Caroli; Jacques Touchon; Piero Calvini; Silvia Morbelli; Fabrizio De Carli; Ugo P Guerra; Laura A Van de Pol; Pieter-Jelle Visser
Journal:  J Neurol       Date:  2008-08-01       Impact factor: 4.849

8.  Prevention of progression to dementia in the elderly: rationale and proposal for a health-promoting memory consultation (an IANA Task Force).

Authors:  S Gillette Guyonnet; G Abellan Van Kan; S Andrieu; J P Aquino; C Arbus; J P Becq; C Berr; S Bismuth; B Chamontin; T Dantoine; J F Dartigues; B Dubois; B Fraysse; T Hergueta; H Hanaire; C Jeandel; S Lagleyre; F Lala; F Nourhashemi; P J Ousset; F Portet; P Ritz; P Robert; Y Rolland; C Sanz; M Soto; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-10       Impact factor: 4.075

Review 9.  Metabolic brain networks in neurodegenerative disorders: a functional imaging approach.

Authors:  David Eidelberg
Journal:  Trends Neurosci       Date:  2009-09-16       Impact factor: 13.837

Review 10.  Biomarkers of Alzheimer's disease.

Authors:  Rebecca Craig-Schapiro; Anne M Fagan; David M Holtzman
Journal:  Neurobiol Dis       Date:  2008-10-28       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.